Skip to content

Psychedelic therapy for body dysmorphic disorder

Shevaugn Johnson, Chris Letheby

Journal of Psychedelic Studies June 23, 2022 DOI: 10.1556/2054.2022.00200 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Qualitative Peer reviewed
Topics Psychedelic-assisted therapy
Keywords Body dysmorphic disorder Psychotherapist Psychopathology Clinical psychology
Citations 1
Key points Proposes that psychedelic-assisted psychotherapy warrants investigation as a treatment for body dysmorphic disorder.

Abstract

Abstract In this opinion piece we propose the investigation of psychedelic-assisted psychotherapy for the treatment of body dysmorphic disorder (BDD). BDD is a psychiatric disorder characterised by appearance-based preoccupations and accompanying compulsions. While safe and effective treatments for BDD exist, non-response and relapse rates remain high. Therefore, there is a need to investigate promising new treatment options for this highly debilitating condition. Preliminary evidence suggests safety, feasibility, and potential efficacy of psychedelic treatments in disorders that share similar psychopathological mechanisms with BDD. Drawing on this evidence, as well as on relevant qualitative reports and theoretical proposals, we argue that it would be worthwhile to conduct a phase 2a study aimed at assessing the safety and feasibility of psychedelic-assisted psychotherapy in BDD. We also offer some suggestions for how future research ought to proceed.

Comparable studies

Other theoretical and historical papers on psychedelic-assisted therapy, most cited first.

Citations in the library

Explore topics